A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis

NCT02749383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrheic Dermatitis

Interventions

DRUG: PAC-14028 cream 0.3%
DRUG: PAC-14028 cream 1.0%
DRUG: PAC-14028 cream vehicle

Sponsor

Amorepacific Corporation